Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-02

Clinical Trial Update: MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness [Phase 2]

View source ↗

Summary

Phase 2 study of MDMA-assisted psychotherapy for anxiety associated with a life-threatening illness has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: Anxiety | Phase 2 | Status: COMPLETED | Results posted: 2021-08-02